ArticleBrain, behavior, & immunity - health2026
Increased inflammatory cytokines in the temporal cortex in autism spectrum disorder.
Article in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alterations in immune and neuroinflammatory processes are evident in neurodevelopmental disorders such as autism spectrum disorders (ASD). While prior studies using cerebrospinal fluid and plasma/serum have identified differences in cytokine levels in ASD when compared with controls, specific changes in postmortem human brain tissue remains poorly characterized. The superior temporal gyrus (STG) is involved in social communication and sensory processing, and is affected in ASD, making it a relevant region for investigating immune-related differences that has not been previously studied. Neuroimmune profiles were measured in STG tissue from 46 postmortem cases: ASD (n = 17), and neurotypical controls (n = 29). Fresh-frozen samples were collected using biopsy punches, and cytokines, chemokines, and growth factors were quantified using multiplexed bead immunoassays. In ASD cases, there were significantly increased levels of inflammatory cytokines in IL-1α, IL-8, IL-18, FLT-3L, FGF-2, G-CSF, M-CSF, MCP3, PDGF-AA and GROa compared to controls. In contrast, there was a significant decrease in RANTES, IFNα2 and IL-4 cytokine levels in ASD. Overall, ASD presented a distinctive STG cytokine profile with increased pro-inflammatory cytokine levels in the absence of an immune regulatory balance. These data highlights that unique neuroimmune pathways occur in neurodevelopmental disorders such as ASD offering insights into potential therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.